S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q2 2022

BVF Partners

Periodo: Q2 2022 Β· Depositato: 2022-08-15
Vedi su SEC EDGAR β†—
AUM
$2.07B
Valore totale del portafoglio
Posizioni
79
Titoli dichiarati
Prima Posizione
RPTX
5.6% $116.0M
Var. Trimestrali
+7 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-08-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RPTXREPARE THERAPEUTICS INC$116.0M5.60%β€”β€”
5.6%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.2M5.51%$5.25$18.95+260.9%
5.5%
RCUSARCUS BIOSCIENCES INC$100.4M4.85%$25.34$30.33+19.7%
4.8%
CGEMCULLINAN ONCOLOGY INC$96.3M4.65%$12.82$17.63+37.5%
4.7%
GHRSGH RESEARCH PLC$92.6M4.47%$9.98$27.01+170.6%
4.5%
MRUSMERUS N V$92.4M4.46%β€”β€”
4.5%
KYMRKYMERA THERAPEUTICS INC$81.5M3.94%$19.69$113.51+476.5%
3.9%
XOMAXOMA CORP DEL$78.7M3.80%$22.28$43.00+93.0%
3.8%
RLAYRELAY THERAPEUTICS INC$73.4M3.55%$16.75$18.65+11.3%
3.5%
CRNXCRINETICS PHARMACEUTICALS IN$68.6M3.31%$18.65$42.23+126.4%
3.3%
KURAKURA ONCOLOGY INC$58.7M2.84%$18.33$11.10-39.4%
2.8%
ACRSACLARIS THERAPEUTICS INC$55.5M2.68%$13.96$5.56-60.2%
2.7%
CTICCTI BIOPHARMA CORP$53.3M2.57%β€”β€”
2.6%
EQRXEQRX INC$49.9M2.41%β€”β€”
2.4%
XENEXENON PHARMACEUTICALS INC$48.6M2.35%$30.42$60.96+100.4%
2.4%
IONSIONIS PHARMACEUTICALS INC$47.3M2.28%$37.02$81.80+121.0%
2.3%
SNDXSYNDAX PHARMACEUTICALS INC$45.4M2.19%$19.24$21.82+13.4%
2.2%
RVMDREVOLUTION MEDICINES INC$44.0M2.12%$19.49$189.24+871.0%
2.1%
ITOSITEOS THERAPEUTICS INC$39.7M1.92%β€”β€”
1.9%
IDYAIDEAYA BIOSCIENCES INC$38.6M1.86%$13.80$37.65+172.8%
1.9%
CNTACENTESSA PHARMACEUTICALS PLC$33.6M1.62%$4.87$40.50+731.6%
1.6%
RLMDRELMADA THERAPEUTICS INC$31.5M1.52%$18.99$6.28-66.9%
1.5%
CINCCINCOR PHARMA INC$31.0M1.50%β€”β€”
1.5%
OLMAOLEMA PHARMACEUTICALS INC$31.0M1.50%$4.07$12.64+210.6%
1.5%
FDMT4D MOLECULAR THERAPEUTICS IN$28.0M1.35%$6.98$13.00+86.3%
1.4%
ACIUAC IMMUNE SA$26.8M1.30%$3.61$2.51-30.5%
1.3%
LXRXLEXICON PHARMACEUTICALS INC$26.3M1.27%$1.86$2.32+24.7%
1.3%
VSTMXXXXVERASTEM INC$23.2M1.12%β€”β€”
1.1%
PNTPOINT BIOPHARMA GLOBAL INC$22.9M1.11%β€”β€”
1.1%
NUVLNUVALENT INC$22.6M1.09%$13.56$123.73+812.5%
1.1%

AttivitΓ  Trimestre su Trimestre

Q2 2022 vs. Q1 2022

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.2M+260.9%
IONSIONIS PHARMACEUTICALS INC$47.3M+121.0%
ANNXANNEXON INC$14.3M
ETNB89BIO INC$12.6M
HLVXHILLEVAX INC$4.2M
CLDXCELLDEX THERAPEUTICS INC NEW$4.2M
CALACALITHERA BIOSCIENCES INC$1.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ARGXARGENX SE$99.7M
LKFTGALAPAGOS NV$64.9M
NGMNGM BIOPHARMACEUTICALS INC$14.6M
DAWNDAY ONE BIOPHARMACEUTICALS I$8.0M
GNCAGENOCEA BIOSCIENCES INC$5.0M
CALACALITHERA BIOSCIENCES INC$3.8M
RDUSRADIUS HEALTH INC$3.3M
ABOSACUMEN PHARMACEUTICALS INC$1.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CNTACENTESSA PHARMACEUTICALS PLC$17.8M+292.7%+731.6%
NUVLNUVALENT INC$13.0M+141.7%+812.5%
SPROSPERO THERAPEUTICS INC$-11.5M+94.9%
IDYAIDEAYA BIOSCIENCES INC$20.7M+74.6%+172.8%
CNCECONCERT PHARMACEUTICALS INC$7.7M+61.1%
FDMT4D MOLECULAR THERAPEUTICS IN$-12.3M+50.4%+86.3%
COGTCOGENT BIOSCIENCES INC$8.9M+47.3%
RPTXREPARE THERAPEUTICS INC$32.6M+41.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VYGRVOYAGER THERAPEUTICS INC$-8.2M-88.2%
PTGXPROTAGONIST THERAPEUTICS INC$-90.3M-73.5%
GBIOGENERATION BIO CO$-10.3M-44.5%
ALPNALPINE IMMUNE SCIENCES INC$-3.4M-19.8%
EQRXEQRX INC$0.3M-11.5%
CINCCINCOR PHARMA INC$0.5M-5.2%
PIRSPIERIS PHARMACEUTICALS INC$-6.6M-4.7%
RLAYRELAY THERAPEUTICS INC$-62.2M-3.2%+11.3%
← Torna agli Hedge Fund